
Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa
Author(s) -
Yoanna S Pumpalova,
Oluwatosin Ayeni,
Wenlong Carl Chen,
Daniel S. O’Neil,
Sarah Nietz,
Boitumelo Phakathi,
Ines Buccimazza,
Sharon Čačala,
Laura Stopforth,
Hayley A Farrow,
Maureen Joffe,
Witness Mapanga,
Judith S. Jacobson,
Katherine D. Crew,
Herbert Cubasch,
Paul Ruff,
Alfred I. Neugut
Publication year - 2021
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-021-06265-w
Subject(s) - breast cancer , medicine , human immunodeficiency virus (hiv) , stage (stratigraphy) , oncology , gynecology , demography , cancer , obstetrics , immunology , biology , paleontology , sociology
Advanced breast cancer (BC) at diagnosis is common in sub-Saharan Africa (SSA), including among women living with HIV (WLWH). In public hospitals across South Africa (SA), 10-15% of women present with stage IV BC, compared to < 5% in the United States (US); 20% of new BC diagnoses in SA are in WLWH. We evaluated the impact of HIV on overall survival (OS) among women with stage IV BC.